Sort   by:  
 Page size 
Genomicsena-DATASET-SC-21-07-2014-10:55:39:527-89 - samples
NSCLC targeted.
EGAD00001000889 | EGA
Genomicsena-DATASET-SC-21-07-2014-10:52:30:961-88 - samples
NSCLC WGS.
EGAD00001000888 | EGA
Genomicsena-DATASET-GENE-CAO-08-02-2016-11:04:25:039-253 - samples
Multi-region Illumina whole-exome and/or whole-genome sequencing on tumor regions collected from early-stage NSCLC patients who underwent definitive surgical resection prior to receiving adjuvant therapy. Patients covered by this dataset: L012, L013, L015, L017
EGAD00001001918 | EGA
Genomicsena-DATASET-TRACERX-25-07-2014-12:27:19:910-271 - samples
Multi-region Illumina whole-exome and/or whole-genome sequencing on tumor regions collected from early-stage NSCLC patients who underwent definitive surgical resection prior to receiving adjuvant therapy. Detected variants were validated on Ion AmpliSeq™ Custom Panel and/or Comprehensive Cancer Gen...
EGAD00001000900 | EGA
GenomicsTRACERx: TRAcking non-small cell lung Cancer Evolution through therapy (Rx). Pilot Study. Multi-region sequencing of early-stage NSCLCs.
Deciphering the complexity of non-small cell lung cancer (NSCLC) evolutionary histories may elucidate the basis for its dismal outcome. We performed multi-region sequencing of early-stage NSCLCs. Spatial dissection revealed branched tumor evolution, with driver mutations occurring before and after s...
EGAS00001000809 | EGA
GenomicsSpatial and temporal diversity in genomic instability processes define early stage lung cancer evolution.
Deciphering the complexity of non-small cell lung cancer (NSCLC) evolutionary histories may elucidate the basis for its dismal outcome. We performed multi-region sequencing on 25 regions from seven early-stage NSCLCs. Spatial dissection revealed branched tumor evolution, with driver mutations occurr...
EGAS00001000840 | EGA
GenomicsWTSI CGP Data access committee
Data Access Committee EGAC00001000000
EGAC00001000000 | EGA
GenomicsTRACERx Pilot Study Data Access Committee
Data Access Committee EGAC00001000198
EGAC00001000198 | EGA
GenomicsThe clonal and mutational evolution spectrum of primary triple negative breast cancers
Primary triple negative breast cancers (TNBC) represent approximately 16% of all breast cancers and are a tumour type defined by exclusion,for which comprehensive landscapes of somatic mutation have not been determined. Here we show in 104 early TNBC cases, that at the time of diagnosis these cancer...
EGAS00001000132 | EGA
GenomicsWhole genome sequencing - samples
Mutational landscapes of primary triple negative breast cancers - WGS
EGAD00001000115 | EGA
Sort   by:  
 Page size